Innovate UK has announced a £9.3 million investment to support eight UK businesses in optimising pharmaceutical process development and manufacturing. The funding, part of the Transforming Medicines Manufacturing Innovation programme, aims to integrate digital, automated, and robotic technologies into the sector.
These technologies, including automation, robotics, and artificial intelligence (AI), are intended to create 'labs of the future'. These laboratories are envisioned to be highly efficient, intelligent, and data-driven, capable of operating 24 hours a day, seven days a week, to accelerate the research, development, and manufacture of medicines.
The investment supports a range of innovations, from next-generation smart platforms for radiopharmaceuticals and synthetic DNA production to AI-enabled laboratories for developing medicines and cancer therapies. It also covers decentralised cell and gene therapy manufacturing, the application of robotics, and wearable technologies to enhance pharmaceutical efficiency and quality.
Hareklea Markides, Innovation Lead for Medicines Manufacturing at Innovate UK, stated that the programme highlights the innovation across the UK. She added that combining expertise in life sciences, advanced manufacturing, and digital technologies could transform medicines development and manufacturing, strengthening the UK's global competitiveness.